Sean E. Aeder

Array ( [id] => 6513026 [patent_doc_number] => 20100216654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'BIOMARKERS OF PROSTATE CANCER AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/531018 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 47496 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216654.pdf [firstpage_image] =>[orig_patent_app_number] => 12531018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886424 [patent_doc_number] => 20080260756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Peptide Inhibitors of iASPP' [patent_app_type] => utility [patent_app_number] => 12/043058 [patent_app_country] => US [patent_app_date] => 2008-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12528 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260756.pdf [firstpage_image] =>[orig_patent_app_number] => 12043058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682264 [patent_doc_number] => 20080248490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Reagents for the detection of protein phosphorylation in Leukemia signaling pathways' [patent_app_type] => utility [patent_app_number] => 12/074224 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22939 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248490.pdf [firstpage_image] =>[orig_patent_app_number] => 12074224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762775 [patent_doc_number] => 08114972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Tumor and infectious disease therapeutic compositions' [patent_app_type] => utility [patent_app_number] => 12/036874 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20536 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114972.pdf [firstpage_image] =>[orig_patent_app_number] => 12036874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663559 [patent_doc_number] => 20080254466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Heregulin-like Factor' [patent_app_type] => utility [patent_app_number] => 12/036630 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 38519 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254466.pdf [firstpage_image] =>[orig_patent_app_number] => 12036630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846383 [patent_doc_number] => 20080182791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Medicament for Improving Prognostic Survival in Therapy of Malignant Tumor' [patent_app_type] => utility [patent_app_number] => 12/035936 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4014 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182791.pdf [firstpage_image] =>[orig_patent_app_number] => 12035936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196305 [patent_doc_number] => 07635753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Prostate cancer and melanoma antigens' [patent_app_type] => utility [patent_app_number] => 12/033229 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8440 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635753.pdf [firstpage_image] =>[orig_patent_app_number] => 12033229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7530244 [patent_doc_number] => 07842466 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-11-30 [patent_title] => 'Colon disease targets and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/070716 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42352 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842466.pdf [firstpage_image] =>[orig_patent_app_number] => 12070716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994766 [patent_doc_number] => 08518651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Marker for identification of tissue type of epithelial ovarian cancer, and method for determination of the occurrence of epithelial ovarian cancer based on tissue type by using the marker' [patent_app_type] => utility [patent_app_number] => 12/527191 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15943 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12527191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4926937 [patent_doc_number] => 20080166300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'CANCER ASSOCIATED PROTEIN PHOSPATASES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/032469 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18476 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166300.pdf [firstpage_image] =>[orig_patent_app_number] => 12032469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5975847 [patent_doc_number] => 20110070221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'GNAQ MUTATIONS IN MELANOMA' [patent_app_type] => utility [patent_app_number] => 12/526449 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19714 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070221.pdf [firstpage_image] =>[orig_patent_app_number] => 12526449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514717 [patent_doc_number] => 20090215024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'BIOMARKERS UPREGULATED IN PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 12/025724 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 27096 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215024.pdf [firstpage_image] =>[orig_patent_app_number] => 12025724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101686 [patent_doc_number] => 20110165178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'DIAGNOSIS OF PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 12/524112 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8506 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165178.pdf [firstpage_image] =>[orig_patent_app_number] => 12524112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32851 [patent_doc_number] => 07785772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Detecting methylated mammalian nucleic acid in stool' [patent_app_type] => utility [patent_app_number] => 12/018273 [patent_app_country] => US [patent_app_date] => 2008-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 4798 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785772.pdf [firstpage_image] =>[orig_patent_app_number] => 12018273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428533 [patent_doc_number] => 20090087843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'MOLECULAR MARKERS' [patent_app_type] => utility [patent_app_number] => 12/016056 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12912 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087843.pdf [firstpage_image] =>[orig_patent_app_number] => 12016056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903927 [patent_doc_number] => 20080113340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Diagnosis and treatment of cervical cancer' [patent_app_type] => utility [patent_app_number] => 12/008532 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11487 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113340.pdf [firstpage_image] =>[orig_patent_app_number] => 12008532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168781 [patent_doc_number] => 07666993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Cynomolgus prostate specific antigen' [patent_app_type] => utility [patent_app_number] => 11/972107 [patent_app_country] => US [patent_app_date] => 2008-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 5429 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666993.pdf [firstpage_image] =>[orig_patent_app_number] => 11972107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860217 [patent_doc_number] => 20080269067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Companion diagnostic assays for cancer therapy' [patent_app_type] => utility [patent_app_number] => 12/005688 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9400 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269067.pdf [firstpage_image] =>[orig_patent_app_number] => 12005688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4926991 [patent_doc_number] => 20080166354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'SUPPRESSION OF INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/964334 [patent_app_country] => US [patent_app_date] => 2007-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19065 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166354.pdf [firstpage_image] =>[orig_patent_app_number] => 11964334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825699 [patent_doc_number] => 20080124744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Antibodies That Specifically Bind PMS2' [patent_app_type] => utility [patent_app_number] => 11/962295 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4798 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124744.pdf [firstpage_image] =>[orig_patent_app_number] => 11962295 [rel_patent_id] =>[rel_patent_doc_number] =>)